ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

CLZR Candela (MM)

3.00
0.00 (0.00%)
14 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Candela (MM) NASDAQ:CLZR NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 3.00 0 01:00:00

- Post-Effective Amendment to an S-8 filing (S-8 POS)

05/01/2010 7:13pm

Edgar (US Regulatory)




As filed with the Securities and Exchange Commission on January 5, 2010

Registration No. 333-161540

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 

 
POST-EFFECTIVE AMENDMENT NO. 1
 
FORM S-8
 
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
 

 
CANDELA CORPORATION
(Exact name of registrant as specified in its charter)

Delaware
04-2477008
(State or Other Jurisdiction of
(I.R.S. Employer
Incorporation or Organization)
Identification No.)

530 Boston Post Road
Wayland, Massachusetts 01778
(Address of Principal Executive Offices, including Zip Code)

1998 Third Amended and Restated Stock Plan
2008 Stock Plan
(Full Title of the Plan)

Paul R. Lucchese
Candela Corporation
530 Boston Post Road
Wayland, Massachusetts 01778
(Name and Address of Agent for Service)

(508) 358-7400
(Telephone Number, including Area Code, of Agent for Service)

Copies to:

Gene Kleinhendler, Adv.
Gross, Kleinhendler, Hodak, Halevy, Greenberg & Co.
One Azrieli Center
Round Building
Tel Aviv, 67021
Israel
Tel: +(972-3) 607-4444
Fabian Tenenbaum
Syneron Medical Ltd.
Industrial Zone, Tavor Building
P.O.B. 550 Yokneam Illit,
20692 Israel
Tel: + (972-73) 244-2202
John M. Mutkoski, Esq.
Goodwin Procter LLP
Exchange Place
Boston, Massachusetts 02109
Tel: (617) 570-1000
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
 
Large Accelerated Filer  o
 Accelerated Filer o
Non-Accelerated Filer  o  (Do not check if a smaller reporting company)
 Smaller Reporting Company x
 
 

 
DE-REGISTRATION OF UNSOLD SHARES AND WITHDRAWAL OF REGISTRATION
STATEMENT

This Post-Effective Amendment No. 1 to Candela Corporation's Registration Statement on Form S-8 (No. 333-161540), filed on August 25, 2009 (the " Registration Statement "), is filed to withdraw from registration all securities of Candela Corporation (the " Registrant ") covered by the Registration Statement.
 
On January 5, 2010, the entire equity interest of the Registrant was acquired by Syneron Medical Ltd. (" Syneron ") through the merger of an indirect wholly-owned subsidiary of Syneron with and into the Registrant (the " Merger ").  As a result of the Merger, every share of the Registrant's Common Stock, $0.01 par value per share, outstanding prior to the Merger was converted into the right to receive 0.2911 ordinary shares of Syneron.  Accordingly, there are no longer any outstanding equity securities of the Registrant other than those owned by Syneron, and the offering pursuant to the Registration Statement has been terminated.
 

2

 
SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Post-Effective Amendment No. 1 to the Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the Town of Wayland, Commonwealth of Massachusetts, on January 5, 2010.
 
  CANDELA CORPORATION
   
 
By: /s/ Gerard E. Puorro
 
Name: Gerard E. Puorro
 
Title: President and Chief Executive Officer

Pursuant to the requirements of the Securities Act of 1933, this Post-Effective Amendment No. 1 to the Registration Statement has been signed by the following persons in the capacities and on the date indicated.
 
Signature
Title
 
Date
/s/ Gerard E. Puorro
Gerard E. Puorro
Chief Executive Officer, President and Director
(principal executive officer)
 
January 5, 2010
                   *               
Robert E. Quinn
Chief Financial Officer and Senior Vice President, Finance & Administration
(principal financial and accounting officer)
 
January 5, 2010
                   *               
Kenneth D. Roberts
 
Chairman of the Board of Directors
 
January 5, 2010
                   *               
George A. Abe
 
Director
 
January 5, 2010
                   *               
Ben Bailey III
 
Director
January 5, 2010
                   *               
Nancy Nager
 
Director
January 5, 2010
                   *               
Douglas W. Scott
Director
January 5, 2010
 
     * By:  /s/ Gerard E. Puorro
        Name: Gerard E. Puorro
        Title: Attorney-in-Fact
 
 
January 5, 2010
 
                                                                                                
3
                    


     

 
 
 
 

1 Year Candela (MM) Chart

1 Year Candela  (MM) Chart

1 Month Candela (MM) Chart

1 Month Candela  (MM) Chart

Your Recent History

Delayed Upgrade Clock